Close Menu

NEW YORK (GenomeWeb) – The GenomeWeb Index climbed nearly 4 percent in March driven by rising stock prices for Natera, Veracyte, and Fluidigm.

Overall, 22 of the 30 stocks that comprise the index saw increases. The 4 percent gain also beat the broader markets last month with the Dow Jones Industrial average essentially flat month over month, while the Nasdaq Composite grew almost 3 percent, and the Nasdaq Biotech was down about 1 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.